Advanced Malignant Solid Tumor Clinical Trials

37 clinical trials for Advanced Malignant Solid Tumor across international registries, including 16 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• YH02 Injection for Intra-tumor Injection Therapy in Advanced Solid Tumors With Unresponsive or Failure-Treated Cases — RECRUITING · PHASE2
• A First in Human Study of PLT012 in Participants With Solid Tumor Cancers — RECRUITING · PHASE1
• A Study of MHB009C in Patients With Advanced Solid Tumors — RECRUITING · PHASE1
• A Study of MHB048C in Patients With Advanced Solid Tumors — RECRUITING · PHASE1
• A Study of MHB042C in Patients With Advanced Solid Tumors — RECRUITING · PHASE1
• A Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Biologic Effect of VG2062 in Patients With Solid Tumors — RECRUITING · PHASE1
• An Early Phase Trial of RPTR-1-201 in Advanced Solid Tumors — RECRUITING · PHASE1
• A Study of MHB088C Combined With MHB039A in Patients With Advanced Malignant Solid Tumors — RECRUITING · PHASE1
• A Study of MHB036C Combined With MHB039A in Patients With Advanced Breast Cancer or Other Advanced Malignant Solid Tumors — RECRUITING · PHASE2
• Phase I/II Study of SCTB39-1 in Advanced Solid Tumours — RECRUITING · PHASE1
• A Study of MHB118C Injection in Patients With Advanced Solid Tumors — RECRUITING · PHASE1
• A Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Biologic Effect of VG2025 in Patients with Solid Tumors — RECRUITING · PHASE1
• Study on the Safety and Efficacy of Intravenous Administration of IDOV-SAFETM in the Treatment of Advanced Solid Tumors — RECRUITING · PHASE1
• A Study of MT027 in Patients with Pleural Malignant Tumors — RECRUITING · PHASE1
• To Evaluate the Phase I Clinical Study of JSKN016 in Chinese Patients With Advanced Malignant Solid Tumors — RECRUITING · PHASE1
• Plasmodium Immunotherapy for Advanced Malignant Solid Tumors — RECRUITING · PHASE1
• Evaluate Preliminary Anti-tumor Activity of Elraglusib in Adult Participants With Advanced Solid Tumors — NOT_YET_RECRUITING · PHASE1
• A Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of VG2025 Intravenous Injection in Subjects With Advanced Solid Tumors — NOT_YET_RECRUITING · PHASE1
• Phase I/II Study of SCTB41 Plus SCTB39-1with or Without Standard Therapy in Advanced Solid Tumours — NOT_YET_RECRUITING · PHASE1
• PRL3-Zumab in Patients With Advanced Solid Tumors — ACTIVE_NOT_RECRUITING · PHASE2
• A Study to Compare the Blood Levels and Safety of Tazemetostat in Participants With Advanced Cancer and Moderate/Severe Liver Impairment to Participants With Advanced Cancer and Normal Liver Function — TERMINATED · PHASE1
• Cannabis extrAct in Oncology Patients for the Treatment of TUmor Related Symptom Burden — NOT_YET_RECRUITING · PHASE2
• A Study Evaluating the Immunotherapy Treatment for Ovarian Cancer and Other Advanced Malignancies. — NOT_YET_RECRUITING · PHASE1
• A Study of JSKN027 in Patients With Advanced Solid Tumors — NOT_YET_RECRUITING · PHASE1
• Safety and Preliminary Efficacy of BNT314 in Cancer Patients With Malignant Solid Tumors — ACTIVE_NOT_RECRUITING · PHASE1
• A Clinical Study of BT02 in Treating Patients With Advanced Lung Cancer — NOT_YET_RECRUITING · PHASE1
• Phase I/II Study of SCTB39G in Advanced Solid Tumours — NOT_YET_RECRUITING · PHASE1
• Study on the Safety and Efficacy of Intratumoral Administration of IDOV-SAFETM in the Treatment of Advanced Solid Tumors — NOT_YET_RECRUITING · PHASE1
• First-in-human Safety and Tolerability of MP0317 in Patients With Relapsed/Refractory Advanced Solid Tumors — TERMINATED · PHASE1
• A Study to Evaluate the Safety, Tolerance, Pharmacokinetics, and Preliminary Antineoplastic Activity of AK132 in Advanced Malignant Solid Tumor — OTHER · PHASE1
• A Clinical Trial to Evaluate the Effect of IAE0972 in Patients With Advanced Malignant Solid Tumors. — OTHER · PHASE1
• A Study to Evaluate the Safety, Tolerability, Pharmacokinetic Properties and Preliminary Efficacy of 9MW3811 in Patients With Advanced Solid Tumors — OTHER · PHASE1
• Clinical Study of a Personalized Neoantigen Cancer Vaccine in Treating Patients With Advanced Malignant Tumor — OTHER · PHASE1
• Clinical Study of a Personalized Neoantigen Cancer Vaccine Combined With Anti-PD-1 and RFA in Patients With Solid Tumors — OTHER · PHASE1
• Clinical Study of VG161 in Subjects With Advanced Malignant Solid Tumors — OTHER · PHASE1
• A Study to Evaluate the Tolerance and Pharmacokinetics of TQB3303 Tablets — OTHER · PHASE1
• Neoantigen Reactive T Cells Combined With SHR-1210 for Chinese Patients With Advanced Refractory Solid Tumors — OTHER · PHASE1

Refine this search